Skip to main content
. Author manuscript; available in PMC: 2021 Feb 4.
Published in final edited form as: J Am Coll Cardiol. 2020 Feb 18;75(6):620–628. doi: 10.1016/j.jacc.2019.11.059

FIGURE 1. Reported Cardiovascular Events During Follow-Up.

FIGURE 1

Events are stratified by cancer type (A), and therapeutic class (B), respectively. *The percentages reported reflect a denominator of the total number of trials within the subgroup considered. CVD = cardiovascular disease; GI = gastrointestinal; GU = genitourinary.